Table 4.
Comparison of acute myeloid leukaemia (AML) measurable residual disease (MRD) by flow cytometric (FC-MRD) and molecular (Mol-MRD) methods using a 0.01% cutoff. Percentages are calculated within each row.
Mol MRD | FC-MRD | Total | |||
---|---|---|---|---|---|
Positive > 5% (Relapse) |
Positive | Indeterminate | Negative | ||
Positive | 1 (3%) | 10 (30%) | 8 (24%) | 14 (43%) | 33 (100%) |
Negative | 0 (0%) | 16 (32%) | 4 (8%) | 30 (60%) | 50 (100%) |
Total | 1 (1%) | 26 (31%) | 12 (15%) | 44 (53%) | 83 (100%) |